{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:25Z","timestamp":1740149785342,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H28-kansei-ippan-001"],"award-info":[{"award-number":["H28-kansei-ippan-001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12328-018-0915-8","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T08:23:36Z","timestamp":1539937416000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Occurrence of hepatocellular carcinoma 24\u00a0years after successful interferon therapy in a patient with chronic hepatitis C: a case report"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-4099","authenticated-orcid":false,"given":"Yuichi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kakisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekatsu","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"915_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/jgh.13589","volume":"32","author":"T Tada","year":"2017","unstructured":"Tada T, Kumada T, Toyoda H, et al. Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis. J Gastroenterol Hepatol. 2017;32:687\u201394.","journal-title":"J Gastroenterol Hepatol"},{"key":"915_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/cncr.20537","volume":"101","author":"A Makiyama","year":"2004","unstructured":"Makiyama A, Itoh Y, Kasahara A, et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer. 2004;101:1616\u201322.","journal-title":"Cancer"},{"key":"915_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.28535","volume":"64","author":"HB El-Serag","year":"2016","unstructured":"El-Serag HB, Kanwal F, Richardson P, Kramer J. Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection. Hepatology. 2016;64:130\u201337.","journal-title":"Hepatology"},{"key":"915_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1478-3231.2004.0956.x","volume":"24","author":"Y Iwasaki","year":"2004","unstructured":"Iwasaki Y, Takaguchi K, Ikeda H, et al. Risk factors for hepatocellular carcinoma in hepatitis C patients with sustained virologic response to interferon therapy. Liver Int. 2004;24:603\u201310.","journal-title":"Liver Int"},{"key":"915_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.14442\/jgfm.16.3_199","volume":"16","author":"G Igarashi","year":"2015","unstructured":"Igarashi G, Endo T, Sawada N, et al. Development of hepatocellular carcinoma in chronic hepatitis c patients 20 years after achieving a sustained virological response with interferon therapy: a report of two cases. J Gen Fam Med. 2015;16:199\u2013203.","journal-title":"J Gen Fam Med"},{"key":"915_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2957\/kanzo.57.27","volume":"57","author":"J Okabe","year":"2016","unstructured":"Okabe J, Fukuda K, Iwamoto T, et al. A case of cirrhosis with hepatitis C virus infection developing hepatocellular carcinoma 20 years after achieving sustained virological response to interferon therapy. Kanzo (Acta Hepatol Jpn). 2016;57:27\u201333 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR7","first-page":"12","volume":"34","author":"H Nakayama","year":"2013","unstructured":"Nakayama H, Iketani S, Okamoto D, et al. Long-term prognosis of patients with chronic hepatitis C who developed hepatocellular carcinoma after a sustained response to interferon therapy. Iwaki Kyoritsu Byoin Ihou (J Iwaki Kyoritsu Gen Hosp). 2013;34:12\u201321 (in Japanese).","journal-title":"Iwaki Kyoritsu Byoin Ihou (J Iwaki Kyoritsu Gen Hosp)"},{"key":"915_CR8","first-page":"68","volume":"41","author":"S Harai","year":"2015","unstructured":"Harai S, Kuratomi N, Fukazawa Y, et al. A case of hepatocellular carcinoma with portal vein tumor thrombosis and bone metastasis developed 20 years after successful interferon therapy to hepatitis C. Yamanashi Kenritsu Chuo Byoin Nenpo (J Yamanashi-ken Central Hosp. 2015; 41:68\u201370 (in Japanese).","journal-title":"Yamanashi Kenritsu Chuo Byoin Nenpo (J Yamanashi-ken Central Hosp."},{"key":"915_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5833\/jjgs.2016.0117","volume":"50","author":"Y Hirohata","year":"2017","unstructured":"Hirohata Y, Yoh Y, Nakamura Y, Kato T, Okamura R. Surgical treatment for hepatocellular carcinoma in a chronic hepatitis C patient 20 years after achieving a sustained virological response. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg). 2017;50:528\u201334 (in Japanese, abstract in English).","journal-title":"Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg)"},{"key":"915_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"},{"key":"915_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep"},{"key":"915_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s12072-016-9754-1","volume":"10","author":"H Nagata","year":"2016","unstructured":"Nagata H, Nakagawa M, Nishimura-Sakurai Y, et al. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. Hepatol Int. 2016;10:956\u201364.","journal-title":"Hepatol Int"},{"key":"915_CR13","first-page":"342","volume":"82","author":"T Sato","year":"2005","unstructured":"Sato T, Okada M, Masumoto A, Takeda N. A case of surgical treatment for hepatocellular carcinoma occurred 10 years after a successful interferon therapy in a patient with chronic hepatitis C. Rinsho to Kenkyu (Jpn J Clin Exp). 2005;82:342\u201343. (in Japanese).","journal-title":"Rinsho to Kenkyu (Jpn J Clin Exp)"},{"key":"915_CR14","first-page":"115","volume":"34","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Suzuki M, Yamada N, et al. A case of hepatocellular carcinoma developed ten years after successful interferon therapy for chronic hepatitis C. Sei Marianna Ika Daigaku Zasshi (St Marianna Med J). 2006;34:115\u201323 (in Japanese, abstract in English).","journal-title":"Sei Marianna Ika Daigaku Zasshi (St Marianna Med J)"},{"key":"915_CR15","first-page":"809","volume":"104","author":"F Sugunami","year":"2007","unstructured":"Sugunami F, Tomiyama Y, Ohmoto K, et al. Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C. Nippon Shokakibyo Gakkai Zasshi (Jpn J Soc Gastroenterol). 2007;104:809\u201314. (in Japanese, abstract in English).","journal-title":"Nippon Shokakibyo Gakkai Zasshi (Jpn J Soc Gastroenterol)"},{"key":"915_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2957\/kanzo.57.252","volume":"57","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Tsuji K, Matsui T, et al. A case of synchronous double cancer of liver metastasis of thymoma and hepatocellular carcinomas, 10 years after achieving sustained virological response treated with peginterferon\/ribavirin in chronic hepatitis C virus infection. Kanzo (Acta Hepatol Jpn). 2016;57:252\u201359 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2957\/kanzo.49.248","volume":"49","author":"J Hanaoka","year":"2008","unstructured":"Hanaoka J, Shimada M, Ikegami T, et al. A case of surgical treatment for hepatocellular carcinoma that developed in a chronic hepatitis C patient who had shown sustained virological response to interferon 11 years before. Kanzo (Acta Hepatol Jpn). 2008;49:248\u201354 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3892\/ol_00000075","volume":"1","author":"K Nojiri","year":"2010","unstructured":"Nojiri K, Sugimoto K, Shiraki K, et al. Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy. Oncol Lett. 2010;1:427\u201330.","journal-title":"Oncol Lett"},{"key":"915_CR19","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.3748\/wjg.v11.i45.7218","volume":"11","author":"Y Ito","year":"2005","unstructured":"Ito Y, Yamamoto N, Nakata R, et al. Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy. World J Gastroenterol. 2005;11:7218\u201321.","journal-title":"World J Gastroenterol"},{"key":"915_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2957\/kanzo.48.48","volume":"48","author":"Y Kawano","year":"2007","unstructured":"Kawano Y, Egami K, Sasajima K, et al. A hepatocellular carcinoma developed following 12 years from sustained virologic response to interferon therapy in a patient with hepatitis C. Kanzo (Acta Hepatol Jpn). 2007;48:48\u201356 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1478-3231.2008.01772.x","volume":"29","author":"T Hayashi","year":"2009","unstructured":"Hayashi T, Tamori A, Nishikawa M, et al. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection. Liver Int. 2009;29:126\u201332.","journal-title":"Liver Int"},{"key":"915_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jso.21176","volume":"99","author":"K Sanefuji","year":"2009","unstructured":"Sanefuji K, Kayashima H, Iguchi T, et al. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. J Surg Oncol. 2009;99:32\u20137.","journal-title":"J Surg Oncol"},{"key":"915_CR23","first-page":"674","volume":"106","author":"T Tsumura","year":"2009","unstructured":"Tsumura T, Takaki S, Aikata H, et al. A case of double cancer of the liver, cholangiocarcinoma and hepatocellular carcinoma detected in a patient with hepatitis C 13 years after diminution of HCV-RNA by interferon treatment. Nippon Shokakibyo Gakkai Zasshi (Jpn J Soc Gastroenterol). 2009;106:674\u2013583 (in Japanese, abstract in English).","journal-title":"Nippon Shokakibyo Gakkai Zasshi (Jpn J Soc Gastroenterol)"},{"key":"915_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2957\/kanzo.50.238","volume":"50","author":"M Yagura","year":"2009","unstructured":"Yagura M, Tanaka A, Kamitsukasa H. A case of hepatocellular carcinoma who cleared hepatitis C virus with interferon therapy 13 years ago. Kanzo (Acta Hepatol Jpn). 2009;50:238\u201343 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1757-1626-2-18","volume":"2","author":"T Mashitani","year":"2009","unstructured":"Mashitani T, Yoshiji H, Yamazaki M, et al. Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report. Cases J. 2009;2:18.","journal-title":"Cases J"},{"key":"915_CR26","first-page":"80","volume":"26","author":"E Bertolini","year":"2013","unstructured":"Bertolini E, Bassi F, Fornaciari G. Deveopment of hepatocellular carcinoma in a non-cirrhotic, long-term responder to antiviral therapy, chronic hepatitis C patient: what kind of surveillance? Ann Gastroenterol. 2013;26:80\u20133.","journal-title":"Ann Gastroenterol"},{"key":"915_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2957\/kanzo.53.763","volume":"53","author":"E Watanabe","year":"2012","unstructured":"Watanabe E, Koizumi Y, Hirooka M, et al. Hepatocellular carcinoma in a chronic hepatitis C patient 15 years after achieving a sustained virological response. Kanzo (Acta Hepatol Jpn). 2012;53:763\u201368 (in Japanese, abstract in English).","journal-title":"Kanzo (Acta Hepatol Jpn)"},{"key":"915_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4030\/jjcs.36.66","volume":"36","author":"R Higuchi","year":"2011","unstructured":"Higuchi R, Yasuda H, Koda K, et al. Hepatocellular Carcinoma Development in Hepatitis-C-Sustained Virological Response to Interferon-Based Therapy After 15-Year Follow-Up. Nippon Gekakei Rengo Gakkaishi (J Jpn Coll Surgeons). 2011;36:66\u201371 (in Japanese, abstract in English).","journal-title":"Nippon Gekakei Rengo Gakkaishi (J Jpn Coll Surgeons)"},{"key":"915_CR29","first-page":"699","volume":"63","author":"N Takeuchi","year":"2011","unstructured":"Takeuchi N, Tada H, Nishida Y, et al. Rapid growing hepatocellular carcinoma in a patient with chronic hepatitis C after 16 years of a sustained and complete response to interferon therapy. Kan Tan Sui. 2011;63:699\u2013705 (in Japanese).","journal-title":"Kan Tan Sui"},{"key":"915_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12328-012-0284-7","volume":"5","author":"M Saito","year":"2012","unstructured":"Saito M, Seo Y, Yano Y, et al. Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review. Clin J Gastroenterol. 2012;5:119\u201326.","journal-title":"Clin J Gastroenterol"},{"key":"915_CR31","first-page":"23","volume":"18","author":"K Ohshima","year":"2012","unstructured":"Ohshima K, Oba N, Kyoden Y, Iseki J, et al. A case of surgical treatment for hepatocellular carcinoma detected in a patient with chronic hepatitis C who had shown sustained virological response (SVR) to interferon 19 years before. Liver Cancer (Tokyo). 2012;18:23\u201335 (in Japanese, abstract in English).","journal-title":"Liver Cancer (Tokyo)"},{"key":"915_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/jvh.12665","volume":"24","author":"H Toyoda","year":"2017","unstructured":"Toyoda H, Tada T, Takaguchi K, et al. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan. J Viral Hepat. 2017;24:472\u201376.","journal-title":"J Viral Hepat"},{"key":"915_CR33","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/hep.26442","volume":"58","author":"Y Asahina","year":"2013","unstructured":"Asahina Y, Tsuchiya K, Nishimura T, et al. alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology. 2013;58:1253\u201362.","journal-title":"Hepatology"},{"key":"915_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.7150\/ijms.17202","volume":"14","author":"K Nirei","year":"2017","unstructured":"Nirei K, Matsumura H, Kumakawa M, et al. Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients. Int J Med Sci. 2017;14:45\u201352.","journal-title":"Int J Med Sci"},{"key":"915_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/jclinpath-2015-203215","volume":"69","author":"S Nanba","year":"2016","unstructured":"Nanba S, Ikeda F, Baba N, et al. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. J Clin Pathol. 2016;69:226\u201333.","journal-title":"J Clin Pathol"},{"key":"915_CR36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1530-0277.2001.tb02314.x","volume":"25","author":"JB Whitfield","year":"2001","unstructured":"Whitfield JB, Zhu G, Heath AC, et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res. 2001;25:1037\u201345.","journal-title":"Alcohol Clin Exp Res"},{"key":"915_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/0003-4819-146-9-200705010-00008","volume":"146","author":"K Ikeda","year":"2007","unstructured":"Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C\u2013related hepatocellular carcinoma: a prospective study. Ann Int Med. 2007;146:649\u201356.","journal-title":"Ann Int Med"},{"key":"915_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12185-009-0359-5","volume":"90","author":"S Kusumoto","year":"2009","unstructured":"Kusumoto S, Tanaka Y, Mizokami M, et al. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol. 2009;90:13\u201323.","journal-title":"Int J Hematol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-018-0915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-018-0915-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-018-0915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:23:49Z","timestamp":1571426629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-018-0915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s12328-018-0915-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}